CP and COVID-19: CP, the major copper-binding ferroxidase in plasma that con-verts Fe(II) to Fe(III) and facilitates iron export, behaves as an acute-phase reactant and is frequently altered during systemic inflammation and viral infection; clinical series in COVID-19 report disturbed circulating copper/CP levels that track with disease severity [211].